NAHRI Journal - Volume 9, Issue 4

2026 MPFS: Ambulatory Specialty Model

Wednesday, October 1, 2025
Reimbursement and Payment Methodologies, Revenue Integrity

Learn about the proposed new ambulatory specialty model in the 2026 Medicare Physician Fee Schedule proposed rule.Read More »

NAHRI Journal - Volume 9, Issue 4

Understanding eligibility requirements

Wednesday, October 1, 2025
Compliance, Coverage, Program Management, Reimbursement and Payment Methodologies, Revenue Integrity

Sarah L. Goodman, MBA, CHCAF, COC, CHRI, CCP, FCS, provides insight into insurance eligibility determinations.Read More »

NAHRI Journal - Volume 9, Issue 4

340B Clawback

Wednesday, October 1, 2025
Billing and Claims, Reimbursement and Payment Methodologies, Revenue Integrity

Gain insights into CMS' proposals for the 340B drug discount program.Read More »

Revenue Integrity Insider

Build your network and move your career forward with the NAHRI Leadership Council

Wednesday, October 1, 2025
News, Program Management, Revenue Integrity

Looking for a strong platform for revenue integrity leaders to network and learn? The NAHRI Leadership Council is your answer. The deadline to apply for the 2026 term is now extended through Wednesday, October 15.Read More »

Revenue Integrity Insider

Revenue integrity professionals strengthen their knowledge and network at 2025 RIS

Wednesday, October 1, 2025
Billing and Claims, Chargemaster and Charge Capture, Coding and Documentation, Compliance, Denials and Appeals, Monitoring and Audits, News, Policies and Procedures, Program Management, Reimbursement and Payment Methodologies, Revenue Integrity

Revenue integrity professionals came together for two days of empowering learning and networking at the 2025 Revenue Integrity Symposium (RIS).Read More »

Leadership Council Insider

How to resolve common errors on skin substitute claims

Thursday, September 18, 2025
Billing and Claims, NAHRI Leadership Council, Revenue Integrity

One of the most common errors seen in skin substitute claims is the inappropriate application of drug waste modifiers, which are as follows:

  • -JW (Drug amount discarded/not administered to any patient)
  • -JZ (Zero drug amount discarded/not administered to any patient)
    • ...Read More »
Revenue Integrity Insider

CMS updates guidance on E/M services

Wednesday, September 17, 2025
Billing and Claims, Coding and Documentation, News, Reimbursement and Payment Methodologies, Revenue Integrity

Review recent billing and coding updates concerning critical care, telehealth, and other evaluation and management (E/M) services.Read More »

Revenue Integrity Insider

How to improve your earning potential and grow your career

Wednesday, September 10, 2025
Program Management, Revenue Integrity

Knowing whether you’re on the right track to advance your career isn’t easy—especially for revenue integrity professionals.Read More »

Pages